Susquehanna International Group, LLP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $666,190 - $699,924	4,596 Added 14.36%	36,591 $5.53 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $1.48 Million - $2.61 Million	17,851 Added 126.21%	31,995 $4.66 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $4.11 Million - $5.33 Million	-37,306 Reduced 72.51%	14,144 $1.68 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $1.91 Million - $2.84 Million	19,103 Added 59.06%	51,450 $7.09 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $1.89 Million - $2.65 Million	19,078 Added 143.78%	32,347 $4.49 Million
Q2 2021 Aug 11, 2021	SELL	$65.78 - $105.02 $3.93 Million - $6.28 Million	-59,787 Reduced 81.84%	13,269 $1.29 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $15.6 Million - $22.4 Million	-243,909 Reduced 76.95%	73,056 $4.99 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $19.7 Million - $29.8 Million	303,400 Added 2236.64%	316,965 $27.2 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $547,477 - $722,830	9,273 Added 216.05%	13,565 $882,000
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $7.29 Million - $18.7 Million	-251,450 Reduced 98.32%	4,292 $314,000
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $2.34 Million - $4.88 Million	85,209 Added 49.97%	255,742 $8.7 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $1.71 Million - $2.41 Million	-41,812 Reduced 19.69%	170,533 $9.28 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $6.73 Million - $8.9 Million	179,952 Added 555.53%	212,345 $8.86 Million
Q2 2019 Aug 16, 2019	BUY	$39.79 - $67.01 $380,869 - $641,419	9,572 Added 41.94%	32,393 $1.42 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $8.08 Million - $13.6 Million	-202,986 Reduced 89.89%	22,821 $999,000
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $5.99 Million - $9.25 Million	173,508 Added 331.76%	225,807 $11.6 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $1.21 Million - $1.75 Million	40,789 Added 354.38%	52,299 $1.93 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $289,628 - $518,559	-12,262 Reduced 51.58%	11,510 $455,000
Q1 2018 May 15, 2018	SELL	$22.49 - $34.56 $165,121 - $253,739	-7,342 Reduced 23.6%	23,772 $612,000
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $470,958 - $819,337	23,041 Added 285.41%	31,114 $839,000
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $190,038 - $308,469	8,073	8,073 $302,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account